Factors specific to retatrutide that might affect real-world outcomes include: The higher side effect rate could drive more discontinuations The heart rate increase might concern prescribers and lead to lower maintenance doses If pricing is higher than tirzepatide, cost barriers could limit access and adherence The more complex triple-agonist mechanism may require more careful monitoring, adding burden Conversely, the additional metabolic benefits (liver fat reduction, possibly better muscle preservation) might improve adherence by providing visible results beyond scale weight, motivating continued use
In the 20-week study, participants receiving exenatide once-monthly achieved similar improvements in blood glucose control (average A1c reductions between 1.3% and 1.5%) as those receiving Bydureon (average A1c reduction of 1.5%)
Important Warnings and Precautions Risk of Thyroid Tumors: Boxed Warning Details Tirzepatide carries a boxed warning regarding thyroid C-cell tumors
Cancer 8, 592603
Our Locations 13550 Reflections Parkway, Suite 4-403, Fort Myers, FL 33907 Naples 2464 Vanderbilt Beach Road, Suite 514, Naples, FL 34109 Lehigh Acres 60 Westminster Street North Suite E, Lehigh Acres, Florida 33936 Copyright 2024
Blood Work CBC, CMP, lipid, thyroid, A1C transparent pricing, no insurance needed